Literature DB >> 26104551

Animal Models for the Pathogenesis, Treatment, and Prevention of Infection by Bacillus anthracis.

Susan Welkos, Joel Bozue, Nancy Twenhafel, Christopher Cote.   

Abstract

This article reviews the characteristics of the major animal models utilized for studies on Bacillus anthracis and highlights their contributions to understanding the pathogenesis and host responses to anthrax and its treatment and prevention. Advantages and drawbacks associated with each model, to include the major models (murine, guinea pig, rabbit, nonhuman primate, and rat), and other less frequently utilized models, are discussed. Although the three principal forms of anthrax are addressed, the main focus of this review is on models for inhalational anthrax. The selection of an animal model for study is often not straightforward and is dependent on the specific aims of the research or test. No single animal species provides complete equivalence to humans; however, each species, when used appropriately, can contribute to a more complete understanding of anthrax and its etiologic agent.

Entities:  

Mesh:

Year:  2015        PMID: 26104551     DOI: 10.1128/microbiolspec.TBS-0001-2012

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  11 in total

Review 1.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

Review 2.  Some Peculiarities of Anthrax Epidemiology in Herbivorous and Carnivorous Animals.

Authors:  Irina Bakhteeva; Vitalii Timofeev
Journal:  Life (Basel)       Date:  2022-06-10

3.  Certhrax Is an Antivirulence Factor for the Anthrax-Like Organism Bacillus cereus Strain G9241.

Authors:  Yuliya I Seldina; Courtney D Petro; Stephanie L Servetas; James M Vergis; Christy L Ventura; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

4.  Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis.

Authors:  Sangjin Park; Soo Youn Jun; Chang-Hwan Kim; Gi Mo Jung; Jee Soo Son; Seong Tae Jeong; Seong Jun Yoon; Sang Yup Lee; Sang Hyeon Kang
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

5.  Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracis.

Authors:  B Kim Lee Sim; Minglin Li; Manuel Osorio; Yun Wu; Tint T Wai; Johnny W Peterson; Eric R James; Sumana Chakravarty; Lixin Gao; Rui Xu; Natasha Kc; Richard E Stafford; William S Lawrence; Linsey A Yeager; Jennifer E Peel; Satheesh K Sivasubramani; Ashok K Chopra; Svetlana Filippova; Stephen L Hoffman
Journal:  NPJ Vaccines       Date:  2017-06-15       Impact factor: 7.344

Review 6.  Current Status and Trends in Prophylaxis and Management of Anthrax Disease.

Authors:  Vladimir Savransky; Boris Ionin; Joshua Reece
Journal:  Pathogens       Date:  2020-05-12

7.  Infection with a Nonencapsulated Bacillus anthracis Strain in Rabbits-The Role of Bacterial Adhesion and the Potential for a Safe Live Attenuated Vaccine.

Authors:  Itai Glinert; Shay Weiss; Assa Sittner; Elad Bar-David; Amir Ben-Shmuel; Josef Schlomovitz; David Kobiler; Haim Levy
Journal:  Toxins (Basel)       Date:  2018-12-01       Impact factor: 4.546

8.  Potential Use for Serosurveillance of Feral Swine to Map Risk for Anthrax Exposure, Texas, USA.

Authors:  Rachel M Maison; Courtney F Pierce; Izabela K Ragan; Vienna R Brown; Michael J Bodenchuk; Richard A Bowen; Angela M Bosco-Lauth
Journal:  Emerg Infect Dis       Date:  2021-12       Impact factor: 6.883

9.  Shifts in microbial community, pathogenicity-related genes and antibiotic resistance genes during dairy manure piled up.

Authors:  Xu Zhang; Chenjie Ma; Wen Zhang; Wu Li; Jialin Yu; Di Xue; Xiaolin Wu; Guangcun Deng
Journal:  Microb Biotechnol       Date:  2020-03-23       Impact factor: 5.813

10.  In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax.

Authors:  Mikhail Martchenko Shilman; Gloria Bartolo; Saleem Alameh; Johnny W Peterson; William S Lawrence; Jennifer E Peel; Satheesh K Sivasubramani; David W C Beasley; Christopher K Cote; Samandra T Demons; Stephanie A Halasahoris; Lynda L Miller; Christopher P Klimko; Jennifer L Shoe; David P Fetterer; Ryan McComb; Chi-Lee C Ho; Kenneth A Bradley; Stella Hartmann; Luisa W Cheng; Marina Chugunova; Chiu-Yen Kao; Jennifer K Tran; Aram Derbedrossian; Leeor Zilbermintz; Emiene Amali-Adekwu; Anastasia Levitin; Joel West
Journal:  ACS Infect Dis       Date:  2021-07-04       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.